Ads
related to: acute lymphoma leukemia in children life expectancy- Dosing & Administration
Learn about dosing and
administration now
- Efficacy Data
Studied against the best available
therapies for myelofibrosis
- Dosing & Administration
consumerpie.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Since the advent of chemotherapy, the prognosis for childhood leukemia has improved greatly and children with ALL are estimated to have a 95% probability of achieving a successful remission after 4 weeks of initiating treatment.
There are multiple forms of leukemia that occur in children, the most common being acute lymphoblastic leukemia (ALL) followed by acute myeloid leukemia (AML). Survival rates vary depending on the type of leukemia, but may be as high as 90% in ALL.
The five-year survival rate is about 35% in people under 60 years old and 10% in people over 60 years old. [3] Older people whose health is too poor for intensive chemotherapy have a typical survival of five to ten months. [3]
In childhood, T-ALL patients can expect a 5-year event free survival and overall survival of, respectively, 70% and 80%. Amongst approximately 25% of children who relapse, survival rate sits at 30-50% and the patients show much poorer prognosis.
Prognosis. Information on prognosis is limited by the rarity of the condition. Prognosis appears to be no different from AML in general, taking into account other risk factors. [9] [10] Acute erythroid leukemia (M6) has a relatively poor prognosis.
Acute promyelocytic leukemia was first characterized in 1957 by French and Norwegian physicians as a hyperacute fatal illness, with a median survival time of less than a week. Today, prognoses have drastically improved; 10-year survival rates are estimated to be approximately 80-90% according to one study.
Ads
related to: acute lymphoma leukemia in children life expectancy